PIP Partnership Contribution
The Partnership Contribution (PC) is one element of the PIP Benefit Sharing System. It is an annual cash contribution to WHO by influenza vaccine, diagnostic and pharmaceutical manufacturers who use the WHO Global Influenza Surveillance and Response System (GISRS). The funds are allocated for pandemic influenza preparedness capacity building, response activities at the time of a pandemic, and the PIP Secretariat for the implementation of the Framework.
Proportional division of funds
Director-General's report to EB131
PIP Advisory Group recommendations to the Director-General on potential use of Partnership Contribution
Methodology of PC Collection
Partnership Contribution standard operating procedures
Distribution of Partnership Contribution among companies
Amounts to be paid by individual manufacturers are based on principles of transparency and equity, and take into account the manufacturers' nature and capacities. Every year WHO issues a questionnaire that identifies potential contributors. It is distributed to existing contributors, to all companies and institutions that conduct research and development in the field of influenza, and to all recipients of PIP biological material recorded in the Influenza Virus Traceability Mechanism (IVTM) database.
PC Preparedness funds are used to strengthen capacities globally, regionally and at country level. The focus is on six areas: laboratory and surveillance; burden of disease; regulatory capacity building; risk communications and community engagement; planning for pandemic product deployment; and influenza pandemic preparedness planning. Activities are implemented according to High-Level Implementation Plan (HLIP) 2018-2023. Details on financial and technical implementation information can be found in PIP Framework progress reports as well as on WHO’s Programme Budget portal.
Achievements resulting from preparedness capacity building activities are presented as stories from the field. The stories communicate the progress made in six areas of work at country, regional and global level. A number of articles and peer-reviewed manuscripts have also been published to document the work achieved using the PIP Partnership Contribution.
Stories from the field
- Improved country preparedness through implementation of the Pandemic Influenza Preparedness Framework partnership contribution, 2018 (2019)
- Pandemic influenza preparedness (PIP) framework: Progress challenges in improving influenza preparedness response capacities in the Eastern Mediterranean Region, 2014-2017 (2019)
- Innovative Pandemic influenza preparedness Framework paves the way for sustainable improvements to pandemic preparedness (2018)
- Special Issue: Influenza Disease Burden, Journal of Influenza and Other Respiratory Viruses, Volume 12, Issue 1 (Jan 2018)
- WHO Eastern Mediterranean Region, Implementation of the Pandemic Influenza Preparedness (PIP) Framework in the Eastern Mediterranean Region: July 2014-August 2016 (2018)
- WHO Influenza
- GISRS and laboratory
- Surveillance and monitoring
- Burden of disease
- Regulatory capacity building
- Risk communications and community engagement
- Planning for deployment
- Influenza pandemic preparedness planning